Innate Immunity Pathways and Breast Cancer Risk in African American and European-American Women in the Women's Circle of Health Study (WCHS)

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gong, Zhihong ^a   Quan, Lei ^a   Yao, Song ^a   Zirpoli, Gary ^a   Bandera, Elisa V ^b   Roberts, Michelle ^a   Coignet, Jean Gabriel ^a   Cabasag, Citadel ^a   Sucheston, Lara ^a   Hwang, Helena ^a   Ciupak, Gregory ^a   Davis, Warren ^a   Pawlish, Karen ^c   Jandorf, Lina ^d   Bovbjerg, Dana H ^e   Ambrosone, Christine B ^a   Hong, Chi Chen ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ESTROGEN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; CRP GENE; CXCL5 GENE; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL1B GENE; ILRN GENE; INNATE IMMUNITY; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TNFA GENE; TYPES OF STUDY; WOMEN CIRCLE OF HEALTH STUDY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMMUNITY, INNATE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 84882584860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072619     Document Type: Article

References (71)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29. doi:10.3322/caac.20138. PubMed: 22237781.
2. Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM, (2008) Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 100: 1804-1814. doi:10.1093/jnci/djn411. PubMed: 19066264.
3. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, et al. (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123-139. doi:10.1007/s10549-007-9632-6. PubMed: 17578664.
4. Fregene A, Newman LA, (2005) Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 103: 1540-1550. doi:10.1002/cncr.20978. PubMed: 15768434.
5. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, et al. (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27: 4515-4521. doi:10.1200/JCO.2008.19.6873. PubMed: 19704069.
6. Disis ML, (2010) Immune regulation of cancer. J Clin Oncol 28: 4531-4538. doi:10.1200/JCO.2009.27.2146. PubMed: 20516428.
7. Medzhitov R, Janeway C Jr., (2000) Innate immunity. N Engl J Med 343: 338-344. doi:10.1056/NEJM200008033430506. PubMed: 10922424.
8. Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, et al. (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20: 15-26. doi:10.1007/s10552-008-9212-z. PubMed: 18704713.
9. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, et al. (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27: 3437-3444. doi:10.1200/JCO.2008.18.9068. PubMed: 19470939.
10. Rody A, Karn T, Liedtke C, Pusztai L, Ruckhaeberle E, et al. (2011) A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res 13: R97. doi:10.1186/bcr3035. PubMed: 21978456.
11. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, et al. (2005) Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46: 464-469. doi:10.1016/j.jacc.2005.04.051. PubMed: 16053959.
12. Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, et al. (2009) Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring) 17: 1420-1427. PubMed: 19197255.
13. Chapman SJ, Hill AV, (2012) Human genetic susceptibility to infectious disease. Nat Rev Genet 13: 175-188. PubMed: 22310894.
14. Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, et al. (2009) Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLOS Genet 5: e1000562.
15. Verrelli BC, McDonald JH, Argyropoulos G, Destro-Bisol G, Froment A, et al. (2002) Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am J Hum Genet 71: 1112-1128. doi:10.1086/344345. PubMed: 12378426.
16. Van Dyke AL, Cote ML, Wenzlaff AS, Land S, Schwartz AG, (2009) Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies. Cytokine 46: 236-244. doi:10.1016/j.cyto.2009.02.003. PubMed: 19356949.
17. Zabaleta J, Schneider BG, Ryckman K, Hooper PF, Camargo MC, et al. (2008) Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother 57: 107-114. doi:10.1007/s00262-007-0358-4. PubMed: 17618436.
18. Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, et al. (2011) Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer. Breast Cancer Res Treat 129: 887-899. doi:10.1007/s10549-011-1520-4. PubMed: 21523452.
19. Lyon DE, McCain NL, Walter J, Schubert C, (2008) Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res 57: 51-58. doi:10.1097/01.NNR.0000280655.58266.6c. PubMed: 18091292.
20. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, et al. (2009) Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 18: 1610-1616. doi:10.1158/1055-9965.EPI-08-0745. PubMed: 19423537.
21. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, et al. (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121: 483-490. doi:10.1007/s00439-006-0315-x. PubMed: 17216494.
22. Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, et al. (2009) Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol,(2009):pp. 871250. PubMed: 19865486.
23. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, et al. (2012) Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res 14: R58. doi:10.1186/bcr3313. PubMed: 22480149.
24. Yu W, Gwinn M, Clyne M, et al. (2008) A navigator for human genome epidemiology. Nat Genet 40: 124-125. doi:10.1038/ng0208-124. PubMed: 18227866.
25. Ruiz-Narváez EA, Rosenberg L, Wise LA, Reich D, Palmer JR, et al. (2011) Validation of a small set of ancestral informative markers for control of population admixture in African Americans. Am J Epidemiol 173: 587-592. doi:10.1093/aje/kwq401. PubMed: 21262910.
26. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P, (2000) Association mapping in structured populations. Am J Hum Genet;67: 170-181. doi:10.1086/302959. PubMed: 10827107.
27. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. doi:10.1093/bioinformatics/bth457. PubMed: 15297300.
28. Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, et al. (2012) Breast cancer genome-wide association studies: there is strength in numbers. Oncogene 31: 2121-2128. doi:10.1038/onc.2011.408. PubMed: 21996731.
29. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, et al. (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362: 986-993. doi:10.1056/NEJMoa0907727. PubMed: 20237344.
30. Manolio TA, (2010) Genome-wide association studies and disease risk assessment. N Engl J Med 363: 166-176. doi:10.1056/NEJMra0905980. PubMed: 20647212.
31. Pennington R, Gatenbee C, Kennedy B, Harpending H, Cochran G, et al. (2009) Group differences in proneness to inflammation. Infect Genet Evol 9: 1371-1380. doi:10.1016/j.meegid.2009.09.017. PubMed: 19804845.
32. Lowe DB, Storkus WJ, (2011) Chronic inflammation and immunologic-based constraints in malignant disease. J Immunother 3: 1265-1274. doi:10.2217/imt.11.113.
33. Mantovani A, (2010) Molecular pathways linking inflammation and cancer. Curr Mol Med 10: 369-373. doi:10.2174/156652410791316968. PubMed: 20455855.
34. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A, (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081. doi:10.1093/carcin/bgp127. PubMed: 19468060.
35. Hall IJ, Moorman PG, Millikan RC, Newman B, (2005) Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol 161: 40-51. doi:10.1093/aje/kwh331. PubMed: 15615914.
36. Rose DP, Vona-Davis L, (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66: 33-38. doi:10.1016/j.maturitas.2010.01.019. PubMed: 20181446.
37. Munoz-Cruz S, Togno-Pierce C, Morales-Montor J, (2011) Non-reproductive effects of sex steroids: their immunoregulatory role. Curr Top Med Chem 11: 1714-1727.
38. Aliyu MH, Salihu HM, Keith LG, Ehiri JE, Islam MA, et al. (2005) Trends in birth across high-parity groups by race/ethnicity and maternal age. J Natl Med Asso 97: 799-804.
39. Marsh EE, Shaw ND, Klingman KM, Tiamfook-Morgan TO, Yialamas MA, et al. (2011) Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab 96: 3199-3206. doi:10.1210/jc.2011-1314. PubMed: 21849524.
40. Flegal KM, Carroll MD, Kit BK, Ogden CL, (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497. doi:10.1001/jama.2012.39. PubMed: 22253363.
41. Lv K, Chen R, Cai Q, Fang M, Sun S, (2006) Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha. Scand J Immunol 64: 164-169. doi:10.1111/j.1365-3083.2006.01786.x. PubMed: 16867162.
42. Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, et al. (2007) TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol 119: 687-696. doi:10.1016/j.jaci.2006.10.028. PubMed: 17208287.
43. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, et al. (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLOS ONE 5: e12402. doi:10.1371/journal.pone.0012402. PubMed: 20811626.
44. Park KS, Mok JW, Ko HE, Tokunaga K, Lee MH, (2002) Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur J Immunogenet 29: 7-10. doi:10.1046/j.0960-7420.2001.00260.x. PubMed: 11841482.
45. Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, et al. (2009) Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114: 347-355. doi:10.1007/s10549-008-0006-5. PubMed: 18409070.
46. Frasor J, Weaver A, Pradhan M, Dai Y, Miller LD, et al. (2009) Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res 69: 8918-8925. doi:10.1158/0008-5472.CAN-09-2608. PubMed: 19920189.
47. Giordani L, Bruzzi P, Lasalandra C, Quaranta M, Schittulli F, et al. (2003) Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem 49: 1664-1667. doi:10.1373/49.10.1664. PubMed: 14500594.
48. Yang Y, Feng R, Bi S, Xu Y, (2011) TNF-alpha polymorphisms and breast cancer. Breast Cancer Res Treat 129: 513-519. doi:10.1007/s10549-011-1494-2. PubMed: 21476000.
49. Reiner AP, Beleza S, Franceschini N, Auer PL, Robinson JG, et al. (2012) Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women. Am J Hum Genet 91: 502-512. doi:10.1016/j.ajhg.2012.07.023. PubMed: 22939635.
50. Crawford DC, Yi Q, Smith JD, Shephard C, Wong M, et al. (2006) Allelic spectrum of the natural variation in CRP. Hum Genet 119: 496-504. doi:10.1007/s00439-006-0160-y. PubMed: 16550411.
51. Arora P, Garcia-Bailo B, Dastani Z, Brenner D, Villegas A, et al. (2011) Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet 12: 95. doi:10.1186/1471-2156-12-95. PubMed: 21756351.
52. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, et al. (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24: 5216-5222. doi:10.1200/JCO.2006.07.1381. PubMed: 17114654.
53. Bièche I, Chavey C, Andrieu C, Busson M, Vacher S, et al. (2007) CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer 14: 1039-1052. doi:10.1677/erc.1.01301. PubMed: 18045955.
54. Zineh I, Aquilante CL, Langaee TY, Beitelshees AL, Arant CB, et al. (2006) CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78). Cytokine 33: 258-263. doi:10.1016/j.cyto.2006.02.008. PubMed: 16567110.
55. Lim EM, Cembrowski G, Cembrowski M, Clarke G, (2010) Race-specific WBC and neutrophil count reference intervals. Int J Lab Hematol 32: 590-597. doi:10.1111/j.1751-553X.2010.01223.x. PubMed: 20236184.
56. Steiner JL, Murphy EA, (2012) Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int J Biol Markers 27: e179-e185. doi:10.5301/JBM.2012.9345. PubMed: 22865298.
57. Rovin BH, Lu L, Saxena R, (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259: 344-348. doi:10.1006/bbrc.1999.0796. PubMed: 10362511.
58. Kanda N, Watanabe S, (2003) 17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol 120: 1058-1066. doi:10.1046/j.1523-1747.2003.12255.x. PubMed: 12787135.
59. Störk S, Baumann K, von Schacky C, Angerer P, (2002) The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res 53: 642-649. doi:10.1016/S0008-6363(01)00461-8. PubMed: 11861035.
60. Ghilardi G, Biondi ML, La Torre A, Battaglioli L, et al. (2005) Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1)-2518 G allele. Clin Chem 51: 452-425. doi:10.1373/clinchem.2004.041657. PubMed: 15681563.
61. Kruszyna L, Lianeri M, Rubis B, Knuła H, Rybczyńska M, et al. (2011) CCL2-2518 A/G single nucleotide polymorphism as a risk factor for breast cancer. Mol Biol Rep 38: 1263-1267. doi:10.1007/s11033-010-0225-9. PubMed: 20563852.
62. Abrahamsson A, Morad V, Saarinen NM, Dabrosin C, (2012) Estradiol, tamoxifen, and flaxseed alter IL-1beta and IL-1Ra levels in normal human breast tissue in vivo. J Clin Endocrinol Metab 97: E2044-E2054. doi:10.1210/jc.2012-2288. PubMed: 22930784.
63. Eklund C, Jahan F, Pessi T, Lehtimäki T, Hurme M, (2003) Interleukin 1Β gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw 14: 168-171. PubMed: 14656692.
64. Ito LS, Iwata H, Hamajima N, Saito T, Matsuo K, et al. (2002) Significant reduction in breast cancer risk for Japanese women with interleukin 1B-31 CT/TT relative to CC genotype. Jpn J Clin Oncol 32: 398-402. doi:10.1093/jjco/hyf081. PubMed: 12451035.
65. Liu J, Zhai X, Jin G, Hu Z, Wang S, et al. (2006) Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 118: 2554-2558. doi:10.1002/ijc.21652. PubMed: 16358261.
66. Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, et al. (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 11: 5718-5721. doi:10.1158/1078-0432.CCR-05-0001. PubMed: 16115908.
67. Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, et al. (2006) Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer 6: 188. doi:10.1186/1471-2407-6-188. PubMed: 16842617.
68. Gaj P, Habior A, Mikula M, Ostrowski J, (2008) Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Med Genet 9: 81. doi:10.1186/1471-2156-9-81. PubMed: 18715515.
69. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, et al. (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A 98: 5199-5204. doi:10.1073/pnas.091056898. PubMed: 11320252.
70. Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, et al. (2002) The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 62: 1093-1102. PubMed: 11861388.
71. Kidd LR, Jones D, Ragin C, Jackson M, McFarlane-Anderson N, et al. (2011) Chemokine-associated genetic variants as predictors of prostate cancer outcomes among men of African descent. Cancer Epidemiol Biomarkers Prev 20: A70. doi:10.1158/1055-9965.EPI-10-0892.